Fulgent Genetics Total Liabilities and Share Holders Equity 2015-2024 | FLGT
Fulgent Genetics total liabilities and share holders equity from 2015 to 2024. Total liabilities and share holders equity can be defined as the total of all liabilities and shareholders' equity.
| Fulgent Genetics Annual Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2023 | $1,235 |
| 2022 | $1,386 |
| 2021 | $1,279 |
| 2020 | $700 |
| 2019 | $89 |
| 2018 | $54 |
| 2017 | $57 |
| 2016 | $58 |
| 2015 | $6 |
| 2014 | $2 |
| Fulgent Genetics Quarterly Total Liabilities and Share Holders Equity (Millions of US $) |
|
|---|---|
| 2024-09-30 | $1,234 |
| 2024-06-30 | $1,232 |
| 2024-03-31 | $1,230 |
| 2023-12-31 | $1,235 |
| 2023-09-30 | $1,358 |
| 2023-06-30 | $1,355 |
| 2023-03-31 | $1,377 |
| 2022-12-31 | $1,386 |
| 2022-09-30 | $1,406 |
| 2022-06-30 | $1,462 |
| 2022-03-31 | $1,466 |
| 2021-12-31 | $1,279 |
| 2021-09-30 | $1,205 |
| 2021-06-30 | $1,050 |
| 2021-03-31 | $999 |
| 2020-12-31 | $700 |
| 2020-09-30 | $247 |
| 2020-06-30 | $96 |
| 2020-03-31 | $89 |
| 2019-12-31 | $89 |
| 2019-09-30 | $61 |
| 2019-06-30 | $56 |
| 2019-03-31 | $56 |
| 2018-12-31 | $54 |
| 2018-09-30 | $55 |
| 2018-06-30 | $56 |
| 2018-03-31 | $55 |
| 2017-12-31 | $57 |
| 2017-09-30 | $59 |
| 2017-06-30 | $59 |
| 2017-03-31 | $59 |
| 2016-12-31 | $58 |
| 2016-09-30 | $23 |
| 2016-06-30 | $27 |
| 2016-03-31 | $0 |
| 2015-12-31 | |
| 2015-09-30 | $0 |
| 2015-06-30 | $0 |
| 2014-12-31 | $2 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.515B | $0.289B |
| Fulgent Genetics, Inc. provides genetic testing services to physicians with clinically actionable diagnostic information. The company's technology platform integrates data comparison and suppression algorithms, adaptive learning software, advanced genetic diagnostics tools and integrated laboratory process which serves primarily to hospitals and medical institutions. Fulgent Genetics is headquartered in Temple City, California. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Veeva Systems (VEEV) | United States | $37.714B | 55.57 |
| Tempus AI (TEM) | United States | $7.994B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $6.961B | 177.00 |
| Inspire Medical Systems (INSP) | United States | $5.693B | 177.56 |
| IRhythm Technologies (IRTC) | United States | $3.453B | 0.00 |
| Privia Health (PRVA) | United States | $2.701B | 225.10 |
| Enovis (ENOV) | United States | $2.693B | 17.94 |
| Azenta (AZTA) | United States | $2.440B | 130.24 |
| Clover Health Investments (CLOV) | United States | $2.230B | 0.00 |
| Omnicell (OMCL) | United States | $2.070B | 67.71 |
| Schrodinger (SDGR) | United States | $1.819B | 0.00 |
| 10x Genomics (TXG) | United States | $1.796B | 0.00 |
| Phreesia (PHR) | United States | $1.669B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.748B | 0.00 |
| Standard BioTools (LAB) | United States | $0.588B | 0.00 |
| Talkspace (TALK) | United States | $0.537B | 0.00 |
| TruBridge (TBRG) | United States | $0.362B | 105.43 |
| Nyxoah SA (NYXH) | Belgium | $0.354B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.343B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.235B | 0.00 |
| Pulmonx (LUNG) | United States | $0.230B | 0.00 |
| American Well (AMWL) | United States | $0.169B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.096B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.069B | 0.00 |
| CareCloud (CCLD) | United States | $0.058B | 0.00 |
| HeartBeam (BEAT) | United States | $0.058B | 0.00 |
| 111 (YI) | China | $0.047B | 0.00 |
| Outset Medical (OM) | United States | $0.044B | 0.00 |
| Zepp Health (ZEPP) | China | $0.042B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.042B | 0.00 |
| Zhongchao (ZCMD) | China | $0.035B | 0.00 |
| Movano (MOVE) | United States | $0.034B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.020B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.018B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.014B | 0.00 |
| MSP Recovery (MSPR) | United States | $0.012B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.012B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.010B | 0.00 |
| Precipio (PRPO) | United States | $0.009B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.006B | 0.00 |
| Syra Health (SYRA) | United States | $0.005B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.005B | 0.00 |
| HeartSciences (HSCS) | United States | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.002B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |